Home
Conditions
Carcinoma, Bronchogenic

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,235 public trials 1,182 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

Study of Anxiety and Avoidance of Others in Patients Previously Treated for Head and Neck Cancer

NCT00483639

Conditions: Anxiety Disorder, Anxiety Disorders, Bronchial Neoplasms, +14 more
Locations: MBCCOP - Meharry Medical College - Nashville Nashville, Tennessee, United States

Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

Oral Topotecan Versus Intravenous Docetaxel In Pretreated, Advanced Non-Small Cell Lung Cancer

NCT00049998

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: GSK Investigational Site Adelaide, South Australia, Australia

GSK Investigational Site Bedford Park, South Australia, Australia

GSK Investigational Site Melbourne, Victoria, Australia

GSK Investigational Site Ringwood East, Victoria, Australia

View all 114 locations

View Trial Details

Completed

Gemcitabine, Carboplatin, and Bortezomib in Advanced or Recurrent Non-Small Cell Lung Cancer

NCT00075751

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations: Southwest Oncology Group San Antonio, Texas, United States

View Trial Details

Completed

A Randomized Phase 2 Study of Erlotinib + ARQ 197 Versus Erlotinib + Placebo in Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

NCT00777309

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Burbank, California, United States

Santa Monica, California, United States

Torrington, Connecticut, United States

Jacksonville, Florida, United States

View all 38 locations

View Trial Details

Completed

Gefitinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

NCT00029003

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +17 more
Locations: Southwest Oncology Group San Antonio, Texas, United States

View Trial Details

Completed

S0341: Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung Cancer

NCT00087412

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma of the Lung, +18 more
Locations: Southwest Oncology Group San Antonio, Texas, United States

View Trial Details

Completed

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

NCT00004074

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +257 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer

NCT00021060

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma of the Lung, +19 more
Locations: Eastern Cooperative Oncology Group Boston, Massachusetts, United States

View Trial Details

Completed

Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

NCT00020709

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma of the Lung, +19 more
Locations: Southwest Oncology Group (SWOG) Research Base San Antonio, Texas, United States

View Trial Details

Completed

A Phase II Trial of Triapine (NSC #663249) in Combination With Gemcitabine as Second Line Treatment of Non-Small Cell Lung Cancer

NCT00077350

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Eastern Cooperative Oncology Group Boston, Massachusetts, United States

View Trial Details

Carcinoma, Bronchogenic

Carcinoma, Bronchogenic trial results

Related conditions